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ABSTRACT
Background: Postoperative atrial ﬁbrillation (POAF)
has been reported to be associated with reduced long-
term survival after isolated coronary artery bypass
grafting surgery. The objective of this study was to
determine the impact of POAF on long-term survival
after valvular surgery.
Methods: The authors retrospectively analysed the
preoperative and operative data of 2986 consecutive
patients with no preoperative history of atrial
ﬁbrillation undergoing ﬁrst valvular surgery (aortic-
valve replacement (AVR), mitral valve replacement or
mitral valve repair (MVR/MVRp) with or without
coronary artery bypass grafting surgery) in their
institution between 1995 and 2008 (median follow-up
5.31 years, range 0.1e15.0). The authors investigated
the impact of POAF on survival using multivariable Cox
regression.
Results: Patients with POAF were older, and were more
likely to have hypertension or renal failure when
compared with patients without POAF. The 12-year
survival in patients with POAF was 45.762.8% versus
61.462.1% in patients without POAF (p<0.001). On
a multivariable analysis, when adjusting for age and
other potential confounding factors, POAF tended to be
associated with lower long-term survival (HR for all-
cause death (HR)¼1.17, 95% CI 1.00 to 1.38, p¼0.051).
The authors also analysed this association separately in
patients with AVR and those with MVR/MVRp. In the
multivariable analysis, POAF was a signiﬁcant predictor
of higher long-term mortality in patients with AVR
(HR¼1 . 2 2 ,C I1 . 0 2t o1 . 4 5 ,p ¼0.03) but not in patients
with MVR/MVRp (HR¼0 . 8 7 ,C I0 . 5 8t o1 . 2 9 ,p ¼0.48).
Conclusions: POAF is signiﬁcantly associated with
long-term mortality following AVR but not after MVR/
MVRp. The underlying factors involved in the
pathogenesis of POAF after MVR/MVRp may partially
account for the lack of association between POAF and
survival in these patients.
INTRODUCTION
Postoperative atrial ﬁbrillation (POAF) is the
most frequent complication following
cardiac surgery. Indeed, POAF occurs in
20e50% of patients, depending on the type
of surgical procedure.
1 POAF is associated
with higher morbidity, prolonged hospital-
isation and increased hospital costs following
cardiac surgery.
1 However, conﬂicting results
have been reported regarding the impact of
POAF on early postoperative mortality.
23
Moreover, recent studies have shown that
POAF is associated with reduced long-term
survival after isolated coronary artery bypass
grafting surgery (CABG) in several large
observational studies.
4e8 Nonetheless, in the
context of valvular surgery, few studies have
examined the impact of POAF on long-term
survival, and these studies have yielded
conﬂicting results.
69Mariscalco and
Engstrom
6 reported that POAF is associated
with lower survival after CABG but not after
valvular surgery, whereas Filardo et al
9 found
that POAF is signiﬁcantly associated with
increased long-term risk of mortality after
aortic-valve replacement (AVR).
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ARTICLE SUMMARY
Article focus
- To investigate if postoperative atrial ﬁbrillation
(POAF) may affect long-term survival following
heart-valve surgery.
Key messages
- POAF is signiﬁcantly associated with long-term
mortality following aortic-valve replacement (AVR).
- POAF is not associated with long-term mortality
following mitral valve replacement/repair.
Strengths and limitations of this study
- This study indicates that POAF is a signiﬁcant
predictor of long-term survival after AVR.
- Hence, additional speciﬁc intervention, possibly
a closer follow-up, should be considered in these
patients.
- This is an observational study, hence causality
between POAF and long-term survival following
AVR cannot be ascertained.
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Open Access ResearchThe objective of this study was thus to examine the
impact of POAF on long-term mortality after valvular
surgery in a large cohort of patients. Further, we deter-
mined whether the impact of POAF on survival following
valvular surgery was inﬂuenced by the treated valve
(aortic or mitral) or the presence of concomitant coro-
nary artery disease (CAD) requiring CABG.
METHODS
Study population
Data on 2986 patients with no preoperative history of
paroxysmal or chronic atrial ﬁbrillation (AF) operated
on for a ﬁrst valvular surgery at the Quebec Heart &
Lung Institute between 1995 and 2008 were prospec-
tively collected in a computerised database and then
retrospectively analysed. Patients with AVR, mitral valve
replacement (MVR) and mitral valve repair (MVRp)
were included. Previous or associated CABG was not
considered as an exclusion criterion. Patients with at
least one of the following criteria were excluded: (1)
concomitant cardiac or vascular procedure (including
tricuspid and pulmonary-valve surgery), (2) double-valve
procedure (concomitant mitral and aortic-valve surgery),
(3) previous valvular surgery and (4) short-term
mortality (deﬁned as death from any cause within
30 days after operation if the patient was discharged
from hospital or within any interval if the patient was not
discharged). The study was approved by the Institutional
Review Board of Quebec Heart & Lung Institute.
Detection and treatment of AF
Detailed information regarding the detection and
treatment of POAF in our institution was previously
reported.
10 11 Brieﬂy, POAF was deﬁned as any sustained
episode recorded during the postoperative hospital stay
and requiring medical and/or electrical cardioversion.
No systematic prophylactic measures were used to
prevent the development of POAF. However, as a general
rule, unless contraindicated, b-blocker medication was
introduced (or reintroduced) in all patients within the
ﬁrst 24 h after surgery. A constant ambulatory electro-
cardiographic (ECG) monitoring was performed in all
patients during the ﬁrst 48 h after surgery. Thereafter,
a standard daily 12-lead ECG was recorded. In every
patient suspected of an arrhythmic event, a standard 12-
lead ECG was performed, and the patient was monitored
with continuous ambulatory ECG until 48 h after the
resolution of the arrhythmia. All patients with POAF
were treated with intravenous amiodarone as a ﬁrst-line
therapy. When needed, electrical cardioversion was
performed.
Outcome
Long-term survival data were obtained from the death
certiﬁcates of the Registry Ofﬁce of the Quebec
government. All-cause mortality was analysed. Survival
follow-up was closed on 31 December 2009.
Statistical analysis
Continuous variables were expressed as mean or
median6SD and were compared using t tests for inde-
pendent samples. Differences in proportion were
compared using a c
2 test. We used the KaplaneMeier
method to estimate survivals. Differences between survival
curves were analysed using the logrank test. The associa-
tion between POAF and risk of all-cause was examined
using individual and multivariable Cox proportional
hazard models. In the multivariable model, we adjusted
for the following potential confounders: age, gender,
diabetes, hypertension, renal failure, chronic obstructive
pulmonary disease, previous myocardial infarction,
previous stroke, current smoking status and left ventric-
ular systolic dysfunction deﬁned as left-ventricular ejec-
tion fraction <50%. The choice of the covariates was
based on current available evidence in the ﬁeld of cardiac
surgery rather than data-driven. Multiplicative interaction
with POAF was tested for the following predeﬁned vari-
ables: type of surgical procedure, type of underlying
valvular dysfunction (regurgitation vs stenosis), severity of
CAD and mechanical-valve implantation. A probability
value <0.05 was considered signiﬁcant. All statistical
analyses were performed with SPSS V.15.
RESULTS
Baseline characteristics of patients with and without POAF
Patients with POAF were older (p<0.001) and had
a higher prevalence of hypertension (p¼0.03) and renal
failure (p¼0.001) (table 1). Patients receiving mechan-
ical valves or current smokers were less likely to have
POAF (p¼0.004 and <0.001 respectively).
Impact of POAF on long-term survival in the whole cohort
The median follow-up was 5.31 years (range:
0.1e15.0 years). Overall, 705 patients (23.6%) died. The
6- and 12-year survival in patients with and without POAF
were 78.161.3% and 45.762.8% versus 83.661.0% and
61.462.1%, respectively (p<0.001, ﬁgure 1).
On multivariable analysis, when adjusting for age and
other potential confounding factors, POAF tended to be
associated with long-term survival (HR¼1.17, 95% CI
1.00 to 1.38, p¼0.051) (table 2).
There was no signiﬁcant interaction with concomitant
CABG, three-vessel disease or mechanical-valve implan-
tation (all p>0.20). Of note, the interaction with the
type of valvular procedure (aortic-valve surgery versus
mitral-valve surgery) was of borderline statistical signiﬁ-
cance (p¼0.09). Consequently, we also report results in
subsets of patients with AVR or with MVReMVRp.
Baseline characteristics of patients with and without POAF
in patients with aortic-valve surgery and in patients with
mitral-valve surgery
Patients with POAF were older and had a higher preva-
lence of renal failure regardless of the surgical proce-
dure (table 1). Patients with hypertension and patients
implanted with mechanical valves were more likely to
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Atrial ﬁbrillation and valve surgeryhave POAF after aortic-valve surgery (p¼0.02 and
p<0.001 respectively), but not after mitral-valve surgery
(p¼0.21 and p¼0.45 respectively). Current smokers
were, in both groups, less likely to have POAF
(p<0.001).
Impact of POAF on long-term survival in patients with aortic-
valve surgery and in patients with mitral-valve surgery
On individual analysis, POAF was associated with
reduced long-term survival in patients who underwent
AVR (75.961.6% vs 82.661.2% at 6 years, p<0.001,
ﬁgure 1), whereas no signiﬁcant difference was observed
in patients with MVR or MVRp (84.462.4% vs
87.862.0%, p¼0.40).
In the multivariable analysis (table 2), POAF remained
a signiﬁcant predictor of long-term mortality in patients
with AVR (HR¼1.22, CI 1.02 to 1.45, p¼0.03). POAF was
not signiﬁcantly associated with survival in patients with
MVR or MVRp (HR¼0.87, CI 0.58 to 1.29, p¼0.48).
DISCUSSION
The major ﬁnding of this study is that POAF following
valvular surgery is associated with long-term mortality in
patients with AVR but not in those with MVR or MVRp.
Impact of POAF on long-term survival in patients with
valvular surgery
Mariscalco and Engstrom
6 found no signiﬁcant associa-
tion between POAF and long-term survival following
valvular surgery, whereas Filardo et al
9 reported that
POAF after AVR is signiﬁcantly associated with long-term
mortality independently of the preoperative disease
severity. Our results are highly consistent with both
studies. Indeed, the association between POAF and
survival was only borderline in the whole cohort, largely
driven by the signiﬁcant association with survival in
patients with AVR. In patients who underwent mitral-
valve surgery, we did not ﬁnd a signiﬁcant impact of
POAF on long-term survival. Our results thus suggest
that the lack of association between POAF and survival
reported in the study of Mariscalco and Engstrom might
be due to the inclusion of a mixed group of patients who
underwent AVR and/or mitral surgery. Furthermore,
our study has more statistical power than the two reports
previously published. The association reported in the
study of Mariscalco and Engstrom (HR¼1.21, CI 0.92 to
1.58) which included 995 patients with isolated valvular
surgery would probably have been statistically signiﬁcant
in a sample of patients as large as ours.
Figure 1 Long-term survival in
patients with or without
postoperative atrial ﬁbrillation
(POAF) in the whole cohort and in
subsets of patients deﬁned
according to the type of valvular
procedure.
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Atrial ﬁbrillation and valve surgeryIt remains unclear why the signiﬁcance of the associ-
ation between POAF and survival differs markedly
according to the type of valvular procedure. In our
population, patients with AVR were mainly patients with
severe aortic stenosis. As aortic stenosis shares some
physiopathology similarities with CAD, the association of
POAF with long-term survival in patients with AVR
appears consistent with the signiﬁcant association
between POAF and long-term survival after isolated
CABG.
4e8 The lack of signiﬁcant association between
POAF and long-term survival after MVR or MVRp may be
explained, at least in part, by differences in the factors
and mechanisms involved in the pathogenesis of POAF
in patients with mitral surgery versus patients with AVR
and/or CABG. The determinants of POAF in patients
with mitral-valve surgery are largely unknown. To the
best of our knowledge, there is no speciﬁc study focusing
on the prediction of the risk for POAF after mitral-valve
surgery. On the other hand, inﬂammation appears to be
the key determinant of POAF following CABG.
11e14
Consistently, pharmacological interventions targeting
postoperative inﬂammation such as glucocorticoids have
been shown to reduce the incidence of POAF after
CABG.
15 Hence, POAF after isolated CABG and AVR
could be a marker of exaggerated inﬂammatory
response to stress, which would in turn translate into
a higher incidence of perioperative morbidity and long-
term mortality. In contrast, POAF after mitral-valve
surgery might be linked to the preoperative features of
mitral valve disease (left atrial dilation and hypertension,
etc), which are, at least in part, corrected by surgery. This
hypothesis has to be tested in future studies. In partic-
ular, mechanistic studies speciﬁcally focusing on the
pathogenesis of POAF after aortic and mitral-valve
surgery are needed.
Lack of association even in patients without long-term
indication for warfarin
It has been previously hypothesised that POAF might have
a weaker effect after valvular surgery because of the indi-
cation of lifelong warfarin therapy after mechanical-valve
implantation.
6 In line with this hypothesis, the long-term
anticoagulation instituted at the time of mechanical-
valve AVR would prevent embolism related to atrial
ﬁbrillation recurrence, thus reducing the impact of
POAF on survival. The results of a large observational
study recently supported this hypothesis.
8 In this study,
anticoagulant treatment at discharge was associated with
decreased long-term mortality in patients who experi-
ence POAF after isolated CABG. However, in our cohort,
there was no signiﬁcant interaction between the associ-
ation of POAF with survival and an indication for long-
term warfarin treatment (ie, patients with mechanical
valves). This lack of modifying effect of lifetime warfarin
treatment would argue against the hypothesis that the
lack of impact of POAF after mitral valvular surgery is
due to the anticoagulation needed for mechanical
valves.
Clinical implications
According to our results, POAF is a signiﬁcant predictor
of long-term survival after isolated or combined
AVR. Consequently, patients with POAF after AVR
should be considered at increased risk for longer-term
events. Hence, additional speciﬁc intervention, possibly
a closer follow-up, should be considered in these
patients.
Limitations
This is a large retrospective monocentre observational
study. As in any observational study, causality between
POAF after AVR and mortality cannot be ascertained.
POAF might be a marker of underlying myocardial
disease, or other conditions, which are associated with
poorer outcome. Besides, the mechanisms involved in
the poorer survival of patients with POAF remain
uncertain. Postdischarge atrial ﬁbrillation recurrence
could be implicated in this excess of mortality. We
unfortunately do not have the data regarding post-
discharge arrhythmia recurrences. Because of these
limitations, the mechanisms by which mortality is
explained by postoperative AF remain speculative, and
the causative link between POAF and survival is still
uncertain.
Table 2 Individual and multivariable analysis of the impact of postoperative atrial ﬁbrillation on survival in the whole cohort and
in patients with aortic or mitral-valve surgery
Whole cohort, n[2986
Patients undergoing aortic-
valve replacement, n[2287
Patients undergoing mitral-
valve surgery, n[699
HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value
Individual analysis 1.41 (1.21 to 1.63) <0.001 1.53 (1.30 to 1.80) <0.001 1.17 (0.81 to 1.68) 0.40
Model 1: adjusted on age,
gender and the type of
surgical procedure
1.18 (1.01 to 1.37) 0.04 1.23 (1.05 to 1.46) 0.01 0.86 (0.59 to 1.25) 0.43
Model 2: adjusted on age,
gender, comorbidities and
the type of surgical procedure*
1.17 (1.00 to 1.38) 0.05 1.22 (1.02 to 1.45) 0.03 0.87 (0.58 to 1.29) 0.48
*The Cox model analysis was adjusted for age, sex, diabetes, hypertension, renal failure, chronic obstructive pulmonary disease, previous
myocardial infarction, previous stroke, current smoking status, left-ventricular ejection fraction <50% and the type of surgical procedure
(concomitant coronary artery bypass grafting, aortic-valve replacement, mitral surgery when applicable).
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Atrial ﬁbrillation and valve surgeryWe had no precise information regarding the post-
discharge management of POAF. Medications intro-
duced after the episode of POAF may have inﬂuenced
our analysis. However, as a general rule, only recurrent
or sustained episodes of AF after the postoperative
period are treated by long-term anticoagulant therapy or
antiarrhythmic drugs. Considering the relatively low
proportion of patients with persistent AF after the early
postoperative period, this residual confounding prob-
ably has a minimal impact on the results.
Constant ECG monitoring was performed only during
the ﬁrst 48 h after surgery. Asymptomatic episodes or
transient episodes of POAF after the ﬁrst 48 h after
surgery might consequently have been underdiagnosed.
This misclassiﬁcation might have biased the results.
Besides, no conclusions can be drawn from our results
regarding the signiﬁcance of asymptomatic POAF.
Conclusion
This study demonstrates that POAF is associated with
long-term mortality in patients with AVR but not in those
with mitral-valve surgery. The underlying factors involved
in the pathogenesis of POAF after mitral-valve surgery
may account for this lack of impact of POAF on survival
in these patients.
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